Lithium Corporation Regains Full Control of Fish Lake Valley Property

By

-

May 7, 2019

Lithium Corporation Regains Full Control of Fish Lake Valley Property

ELKO, NV / ACCESSWIRE / May 7, 2019 / Lithium Corporation (OTCQB: LTUM) (“LTUM” or “the Company”), a North American company focused primarily on energy metals for the growing energy storage sector and high tech industries, is pleased to announce the February 10th, 2016 option agreement pertaining to their Fish Lake Valley prospect has been terminated with Lithium Corporation retaining 100% ownership of the subject property.

Lithium Corporation acquired the Fish Lake Valley prospect in 2009. In the 1800s, it operated as a producer of borates from a lithium/boron/potassium rich brine recovered from the east side of the salt flats. The prospect is currently comprised of one hundred and forty three – 80 acre Association Placer claims for a total of approximately 11,360 acres (4,597 hectares), covering the most prospective portions of the playa. These flats lie at an elevation of 4684 feet (1427 meters) above sea level and are ideally suited for a lithium brine operation. In addition to the flat geography, the valley is arid and there are considerably more evaporative days in the year than days where conditions are not conducive to evaporation. The property is easily accessible via Highways 6 & 773 and several miles of well maintained gravel roads. In addition to the road network, infrastructure is very good in Fish Lake Valley with power, fuel and phone service available locally, and most supplies available in Tonopah approximately 40 miles (60 kms) east.

As the crow flies the property is only 22 miles (35 kms) west across the Silver Peak Range from Albermarle’s Silver Peak lithium brine operation, the only active commercial lithium mine in the United States. LTUM’s Fish Lake Valley lithium-in-brine prospect is quite analogous to the Silver Peak lithium brine operation as:

Hosts a documented lithium enriched brine both near surface and at relatively shallow depths has not been fully delineated, and explored to depth.

Brine hosted in the same sediments/rocks as the mineralized brine at Silver Peak.

Proximal to lithium enriched geothermal waters which are likely at least in part responsible for the formation of the lithium-in-brine deposits that occur both here and at Silver Peak.

Structure conducive to the formation of a Silver Peak style deposit. At the junction of a possible splay of the northeasterly trending Death Valley – Furnace Creek fault system and the northwesterly trending Grand Central fault which is possibly related to, or an extension of, the Cross Central fault that is an integral part of the system at the Silver Peak mine.

The Company intends to concentrate its time and resources in the short term reviewing the work done by the Optionee during the past three years, following this a plan will be formulated for developing the Fish Lake Valley property.

About Lithium Corporation

Lithium Corporation is an exploration company based in Nevada devoted to the exploration for energy storage related resources throughout North America, and looking to capitalize on opportunities within the ever-expanding next generation energy storage markets. The Company maintains a strategic alliance with Altura Mining, an ASX listed natural resource development company that is currently ramping up production at its 100% owned world-class Pilgangoora lithium pegmatite property in Western Australia. Website: www.lithiumcorporation.com

Contact Info

Tom Lewis, CEO
Lithium Corporation
775-410-5287
info@lithiumcorporation.com

Notice Regarding Forward-Looking Statements

This current report contains “forward-looking statements,” as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future.

Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with mineral exploration and difficulties associated with obtaining financing on acceptable terms. We are not in control of minerals prices and these could vary to make development uneconomic. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

Marijuana Company of America Issues 2019 Shareholder Letter

By

Administrator

-

May 7, 2019

Marijuana Company of America Issues 2019 Shareholder Letter

ESCONDIDO, Calif., May 07, 2019 (GLOBE NEWSWIRE) — via NetworkWire – MARIJUANA COMPANY OF AMERICA INC. (“MCOA” or the “Company”) (OTCQB: MCOA), an innovative hemp and cannabis corporation, today announces that on May 1, 2019, the Company mailed a letter to its shareholders to update them on recent developments and new business opportunities. In the letter, the Company provided a discussion on its two current acquisitions underway a review of its recent financial and operating performance and details of its new Viva Buds™ brand that will serve as a manufacturing, distribution and retail delivery service for cannabis products in the state of California.

Recent Company highlights include:

Marijuana Company of America’s global expansion with the debut of its hempSMART™ products in the UK
The Company’s established joint venture in California to operate a California

cannabis delivery service named Viva Buds™

Details of the joint venture partnership with Global Hemp Group, which completed a successful first harvest late in 2018 and is now in position to monetize its hemp biomass
A strategic partnership with MassRoots (OTCQB: MSRT) to promote its

hempSMART CBD product line

“Our shareholder letter addresses our hemp research and growth business expansion, and the two joint ventures we started with Global Hemp Group Inc. last year, which includes a working hemp farm in Oregon that just completed its successful first harvest in late 2018,” said Mr. Don Steinberg, Chairman and CEO of Marijuana Company of America. “We are confident to now be strategically positioned to drive more revenue and expand exponentially into new markets with our products and business growth methods.”

To read the letter to shareholders in full, please visit: http://marijuanacompanyofamerica.com/investor-relations/

About Marijuana Company of America Inc.

MCOA is a corporation that participates in: (1) product research and development of legal hemp-based consumer products under the brand name hempSMART™ which targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreational use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About Our hempSMART Products Containing CBD
The United States Food and Drug Administration (FDA) has not recognized CBD as a safe and effective drug for any indication. Our products containing CBD derived from industrial hemp are not marketed or sold based upon claims that their use is safe and effective treatment for any medical condition as drugs or dietary supplements subject to the FDA’s jurisdiction.

Forward Looking Statements
This news release contains “forward-looking statements” that are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, “intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time to time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

Contact:
ir@marijuanacompanyofamerica.com
888-777-4362

Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

For more information, please visit the Company’s websites at:

MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWire/MCOA

Medical Marijuana, Inc. Subsidiary Kannaway® Unveils New CBD Coffee and Tea Pods

By

Administrator

-

May 7, 2019

Medical Marijuana, Inc. Subsidiary Kannaway® Unveils New CBD Coffee and Tea Pods

PR Newswire

SAN DIEGO, May 7, 2019

SAN DIEGO, May 7, 2019 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that its subsidiary Kannaway® has released its new Single-Serving Coffee and Tea Pods, infused with 10 mg of hemp-derived cannabidiol (CBD) per pod.

Kannaway Coffee & Tea

Kannaway® French Roast Coffee cups are made with 100 percent premium Arabica coffee beans expertly batch-roasted by a fifth generation roast master. Kannaway® Rooibos and Citrus Tea cups are a floral blend of antioxidant-rich and caffeine-free tea. Compatible with most single-serve brewing systems, they are quick and easy to use.

“Kannaway’s Single-Serving CBD-infused Coffee and Tea Cups provide a fast and pre-measured way to ingest your daily dose of CBD without disturbing your daily routine,” said Kannaway® CEO Blake Schroeder. “These new products fill a need in the CBD market that very few products currently offer and we are confident that consumers will love the convenience they provide.”

According to a report by Cowen & Co., the CBD market alone is expected to hit $16 billion by 2025. Of the CBD products currently on the market, most are in the form of liquid tinctures or topicals, making CBD-infused coffee and tea a large market opportunity.

“By providing consumers the option to start their day with CBD-infused coffee or wind down at the end of the night with CBD-infused, caffeine-free tea, Kannaway is making it easier to fit CBD into a variety of lifestyles and routines,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “CBD is being researched to provide a variety of therapeutic benefits and we are proud to bring high-quality products to our consumers in the U.S. and abroad.”

Shop the entire line of Kannaway® Single-Serving CBD-infused Coffee and Tea pods in the Kannaway® online store.

About Kannaway®
Kannaway® is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway® currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.

About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.

To see Medical Marijuana, Inc.’s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

LEGAL DISCLOSURE
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

CONTACT:

Public Relations Contact:

Andrew Hard
Chief Executive Officer
CMW Media
P. 858-264-6600
andrew.hard@cmwmedia.com
www.cmwmedia.com

Apple’s iPhone sales fall 17% in first quarter as flagship product struggles

By

Administrator

-

May 3, 2019

Apple’s iPhone sales fall 17% in first quarter as flagship product struggles

Apple’s iPhone sales fell 17% in the first three months of the year as the company’s flagship product continued to struggle.

The tech company reported revenues of $31.05bn in iPhone revenues for the quarter, the majority of the $58.bn in revenues Apple brought in over the three months.

The news was less gloomy than expected and Apple’s shares spiked 5% in after hours trading as Apple announced it was buying back another $75bn of its shares.

The company made a profit of $11.6bn – ahead of expectations. But this quarter marked another quarterly decline in profit and revenue as the company struggled to move beyond the iPhone.

In January Apple reported its first decline in revenues and profits in over a decade as slowing sales of iPhones and an economic slowdown in China took their toll.

Those results came after chief executive Tim Cook shocked investors by issuing Apple’s first profits warning since 2002 citing “the magnitude of the economic deceleration, particularly in greater China.”

The company has stopped reporting unit sales of iPhones – leaving analysts searching other sources of data for their estimates. Most don’t expect a recovery in sales until the next generation of phones, using the super-fast 5G network, are launched, likely to be in 2020.

In the meantime Apple is repositioning itself as a services and software company as well as the manufacturer of hardware.

“Investors are slowly shifting their focus away from the iPhone cycle and valuing the company more based on the ecosystem of hardware, software, and services, but it will take several years for this to become consensus,” Gene Munster, managing partner of Loup Ventures, wrote in a blog post this week.

Apple’s services segment, which includes products like Apple Pay, Apple Care and Apple Music, posted a record $11.5bn after reporting a record $10.9bn in the last quarter.

Last month Apple unveiled a host of new subscription services, Apple TV+, at a star-studded event attended by Oprah Winfrey, Steven Spielberg, Reese Witherspoon and Big Bird. It has also announced Apple Card, a credit card backed by Goldman Sachs and MasterCard.

“Our March quarter results show the continued strength of our installed base of over 1.4 billion active devices, as we set an all-time record for services, and the strong momentum of our wearables, home and accessories category, which set a new March quarter record,” said Tim Cook, Apple’s chief executive officer.

Yoram Wurmser, eMarketer principal analyst, said: “The long-term growth in services and, to a less extent, other devices depends on having as many users as possible in the Apple ecosystem, and that’s still primarily about the iPhone. So, it’s worrisome that iPhone sales fell 17% year on year. Moreover, sales in China fell 22%, so the issues in that market remain. Services did rise 16% and wearable, home and accessories grew a strong 30%, but the long-term growth of the company still depends directly and indirectly on iPhone sales.”

Hemp-Derived CBD Company to Benefit From Multiple Industry Trends

By

Administrator

-

May 3, 2019

Hemp-Derived CBD Company to Benefit From Multiple Industry Trends

The cannabis industry is growing worldwide and cannabidiol (CBD) is a huge part of its success. In the U.S., the most positive estimates predict that the hemp-derived CBD market alone could reach $22 billion by 2022. This expected growth will be spurred, in part, by the legalization of hemp-derived CBD via the 2018 Farm Bill. The growing interest in natural healthcare products combined with awareness of CBD as such a product will also be a huge contributing factor. One company, PotNetwork Holdings, is positioned to greatly benefit from these trends with multiple companies and diverse brands focused on CBD.

CBD market expected to grow dramatically

Market estimates for CBD have traditionally maxed out in the low billions. For example, one study predicts a market of $1.15 billion for both hemp and marijuana-derived CBD by 2020. However, CBD and cannabis industry research group Brightfield Group more recently released a report estimating that the U.S. market for hemp-derived CBD alone would hit $22 billion by 2022. This staggering estimate caught many by surprise but Brightfield Group is standing behind its prediction.

Brightfield Group representative Bethany Gomez explained how they came up with this figure, stating, “We have interviewed hundreds of people in the industry, surveyed thousands of consumers, conducted market analysis across literally millions of data points.” She described her research team as “highly conservative analysts” and, based on their findings, considers their estimate to also be “conservative.”

Gomez also pointed out that she has covered consumer markets for over a decade and has “never seen anything like the explosion that we’re seeing right now in CBD” even given that fact that it operated, at the time she wrote, in a “bizarre legal gray area.” Gomez finds the interest remarkable given that, prior to the passage of the 2018 Farm Bill, CBD was publicized largely by word-of-mouth. She contributes its amazing spread both to a recognition that it addresses a wide range of health issues and that it has also become a “trendy, new ingredient” for products seeking to differentiate themselves in the market. Based on everything she has seen and everything her research team uncovered, she maintains that “CBD is the next healthcare phenomenon.”

Factors in the growth of the CBD market

Though CBD derived from marijuana is also expected to grow, hemp-derived CBD’s expected growth will be driven by both legal and health-related concerns. The legal aspect is fairly straightforward. The 2018 Farm Bill legalized hemp and hemp-derived CBD products nationwide. However, the process of both federal and state regulation is still unfolding which does throw significant uncertainty into the works. Nevertheless, the time for hemp-derived CBD is now.

While the Farm Bill helped publicize CBD, announcements of new partnerships with celebrities like Martha Stewart have taken CBD excitement to another level since the Brightfield Group report was released. But the underlying cause of this excitement and the interest of figures like Stewart is driven by the growing recognition of CBD’s status as a health product. While the research looks promising, it is the anecdotal reports of phenomenal cures and relief from such conditions as pain and inflammation that is driving interest.

Both globally and in the U.S., the health and wellness trend has been growing for many years. Consumers are turning to a wide range of products and practices to take responsibility for their own healthcare. Supplements, alternative beauty products and yoga classes are some of the areas in which massive growth has been seen prior to the CBD trend. In fact, just as health and wellness can now be said to be more than a trend, interest in CBD seems most likely to be here to stay.

Emerging Diversified Cannabis Company

One cannabis industry company expected to maximize benefits from the CBD craze is PotNetwork Holdings Inc. PotNetwork Holdings wholly owns multiple CBD companies and brands. The company’s portfolio includes other sectors of the growing cannabis industry as well but hemp-derived CBD is its strong point. From CBD research and production firm First Capital Venture to retailer Diamond CBD, PotNetwork Holdings has a strong base in CBD product creation and distribution. But it also has a wide range of individual products addressing all relevant sectors from adult health and beauty to pet care.

Hemp-derived CBD brands from PotNetwork Holdings are distributed both through Diamond CBD’s ecommerce operation and through a network of over 10,000 third-party retail locations. The combination gives PotNetwork Holdings full national distribution at a time when the whole nation is becoming aware of CBD.

In a detailed report from Harbinger Research, POTN is deemed a Strong Speculative Buy for multiple reasons, including the 2018 Farm Bill, PotNetwork Holdings’ diverse portfolio of brands and its strong initiatives for 2019.

Facebook will launch its own cryptocurrency

By

Administrator

-

May 3, 2019

Facebook will launch its own cryptocurrency

Facebook could integrate cryptocurrency payments into its social network, rewarding users with micropayments for viewing advertisements or allowing people to send payments through messaging apps.

The social media giant has talked with Visa and MasterCard about working together on the project, known internally as Project Libra, The Wall Street Journal reported. Facebook wants to use digital currency on the blockchain with valuation tied to the U.S. dollar.

The news comes one day after CEO Mark Zuckerberg’s speech at Facebook’s F8 annual software developer conference in San Jose, Calif. where he talked about the importance of digital payments.

“When I think about all the different ways that people interact privately, I think payments is of the areas where we have an opportunity to make it a lot easier,” Zuckerberg said.

The service could also be embedded into third-party apps and websites when users log-in with their Facebook profiles.

Facebook has been under fire for privacy issues in the United States and in Britain in recent years. The company’s current freemium business model makes users the product that it builds profiles on that in turn is sold to advertisers.

“Payments and commerce are Facebook’s only way out,” Henry Liu, a former Facebook employee and managing partner of YGC, a blockchain investment firm, told CNBC.

Uber’s IPO 6 Reasons Its Numbers Don’t Add Up

By

Administrator

-

May 3, 2019

Uber’s IPO : This Unicorn Story a Myth

The most anticipated IPO in many years is set for this month, but is the Uber unicorn a real fairy tale. The price for the UBER ticker symbol is set between $44 to $50 for its public debut on May 10^th.

1. Lyft IPO should be a warning.

Lyft, the rideshare company and Ubers main competitor in the US went public and Lyft stock slid 20% in a matter of days. Lyft is by all accounts a stronger, faster growing company than Uber.

2. Uber has slow growth

Uber’s profitability, slowing growth and limited financial disclosures are just a few reasons why this once Mammoth company is now not getting the investor love it once had. Silicon Valley has seen enough Snapchats to know when it’s time to hang up your hat on over-valued stock.

3. Uber Drivers will leave in masses after IPO

Uber will start to limit incentives for drivers as soon as it goes public to help boost profits. As many of their contracted drivers see perks go down they will switch to driving with the more contractor friendly Lyft. Uber has evaded treating drivers as employees, which leaves their drivers free to drop the company and switch to Lyft.

Uber will find it will be difficult to keep many new drivers when more share of their earnings with less benefits will be handed to the parent company who treats drivers like the black sheep of the family instead of bread winners.

Uber’s attempt to squeeze drivers in 2017, along with a series of PR disasters that led to the #DeleteUber campaign, drove both riders and drivers to other platforms, like Lyft. According to data firm Second Measure, Uber’s share of the U.S. rideshare market declined from 82% at the beginning of 2017 to 71% at the end of the year.

4. Uber Legal Troubles

Uber was a thorn in the side for regulators in many countries and has a history of less than honorable behavior. The company had its fair share of negative press, and has snubbed its nose at many regulators for years. Uber has been banned in cities and states throughout the US, Europe and Asia. Uber is landmine and even with an IPO, the company will have an uphill battle to fix its legal and regulatory issues in many countries.

Companies like Bolt in Europe have shown that it’s possible to operate a ridesharing app profitably, but you can’t do so while simultaneously trying to achieve a dominant market share worldwide. Uber can be a huge company, or it can be a profitable company, but it can’t be both.

5. Ubers numbers don’t add up

Uber believes that it is unstoppable and their claim that they will control 15% of the global economy is at best insane. The company prospectus looks more like a pennystock pump and dump than a serious reflection of the companys true potential and current economic situation.

6. Uber regime changes

Many of the original members of Uber have moved on or been thrown out. The CEO and Founder Travis Kalanick along with CFO and the team that heralded Ubers initial success have all moved on or been kicked out, leaving seasoned Silicon Veterans to hold the store.

Is Joe Biden Good For Cannabis Industry

By

Administrator

-

May 2, 2019

Is Joe Biden Good For Cannabis Industry ?

Former Vice President Joe Biden has announced he is throwing his hat in the ring as a candidate in the 2020 Democratic Presidential Primary.

The grey haired politician made an appearance on the View last week with all the scripted emotional drama of an E Entertainment “reality show”, the cheers, the hugs and the tears.

The amiable “Uncle Joe” persona is great for daytime viewing and middle class white America soccer moms, but what about Joe as a politician and supporter of legalization of the Cannabis industry.

Joe Biden’s previous record shows a disaster for the cannabis markets and industry as he has a history of being the worst advocate for marijuana legalization.

JOE BIDEN CREATED THE “DRUG CZAR”.

Biden remains one of the original architects of America’s drug war. While his peers have retired, the 76 year old still remains and brings political clout with him.

The drug policies Joe Biden personally put in place during his 50 years as a politician are still be being felt in many communities. His influence over drug policy and mass incarceration began in the 1980s, when, as a senator from Delaware, he served as chair of the powerful Senate Judiciary Committee.

A lot of politicians from both parties vocally supported the war on drugs back in the days of “Just Say No.” But it was Joe Biden who pretty much single handedly dreamed up the idea of a cabinet level “Drug Czar”—a term he coined in a 1982 interview with the New York Times. Seven years later, after working in tandem with the Reagan administration, he saw that dream come to life when the White House created the Office of National Drug Control Policy (ONDCP).

A 1989 report to Congress put it in dollar figures:

No attempt should be made to disguise the fact that significant new resources will be required to pay for the many proposals advanced in this report… Last February, this Administration requested nearly $717 million in new drug budget authority for Fiscal Year 1990. Now, after six months of careful study, we have identified an immediate need for $1.478 billion more. With this report, the Administration is requesting FY 1990 drug budget authority totaling $7.864 billion—the largest single-year dollar increase in history.

“The Director shall ensure that no Federal funds appropriated to the Office of National Drug Control Policy shall be expended for any study or contract relating to the legalization (for a medical use or any other use) of a substance listed in schedule I of section 202 of the Controlled Substances Act (21 U.S.C. 812) and take such actions as necessary to oppose any attempt to legalize the use of [such] a substance (in any form).”

While on his tour for the Presidency, Joe should be made to answer some serious questions to either make a late conversion to cannabis legalization or explain why not. Either way, it’s not a good look. He’s also open to charges that his signature piece of legislation in the US Senate—the 1994 Violent Crime Control and Law Enforcement Act—played a key role in supercharging the for-profit prison industry and turning the United States into the nation with the world’s highest incarceration rate.

REEFER MADNESS IS STILL JOE BIDEN’S TRUTH

Biden remains one of very few prominent Democrats who’ve still failed to endorse cannabis legalization at the federal level. A policy that’s currently supported by 62% of Americans—including 45% of Republicans—and is already the law of the land in ten states remains too radical for him to sign off on.

“There’s a difference between sending someone to jail for a few ounces and legalizing it,” he said. “The punishment should fit the crime. But I think legalization is a mistake. I still believe [marijuana] is a gateway drug.” Joe Biden 2010, ABC News interview.

Before we start the great race for the 2020 Presidency we need to make good judgement calls and see how lack of forethought can impact America. It can’t be just a matter of voting because of political party anymore.

Evitrade Closes Terms to Acquire Medical Products Marketplace APP

By

Administrator

-

April 29, 2019

Evitrade Closes Terms to Acquire Medical Products Marketplace APP

April 26, 2019
OTC Disclosure & News Service

Vancouver, BC, Canada —

This release includes additional documents. Select the link(s) below to view.

2019-04-26 Acquisition of Medical Marketplace APP_ FINAL.pdf

EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: EVAHF) is pleased to announce that the Company has conditionally closed terms for a binding agreement to acquire the software and portal for a medical marketplace app.

The company see this asset as an opportunity to fulfill a key link as medical marketplace connector. It is a marketplace connection app which connects buyers with sellers. The app serves two functions: one, is a marketplace tool for finding local medical cannabis dispensaries and product overview. The second function is to provide a marketplace for new and used medical products. A planned future feature for both functions in the app will be capability the scheduling of secure pick-up and delivery of products to ensure user confidentiality and privacy.

The purchase price of the transaction is $1,450,000 and is to be completed based on milestones with the issuance of 7,037,037 shares at a deemed price of $0.135 and cash payments.

EViTrade continues to fulfill its commitment to elevate the human condition through advanced medical solutions, research and effective health and wellness products.

Contact:

EVITRADE Health Systems Corp.

(formerly Auxellence Health Corporation)

Email info@evahealthsystems.com or ceo@auxellence.com Website http://www.evahealthsystems.com

CSE Micro-site: http://thecse.com/en/listings/technology/evitrade-health-systems-corp US OTC Markets (OTCQB): http://www.otcmarkets.com/stock/EVAHF/news

About EVITRADE Health (CSE: EVA, OTCQB: EVAHF)

EVITRADE Health Systems Corp. (formerly, Auxellence Health Corporation), is a technology company specializing in the Health and Life Sciences sector looking to deliver effective personalized health solutions with a higher degree of predictability and consistency.

The Company is focused on the following areas to help improve health: personalized medical care (including CBD usage monitoring and effects on the cardiovascular system), molecular biology, nutraceutical solutions and genetic tailoring.

Through its subsidiaries focus on technologies involved in extracting and purifying CBD extracts for its personalized healthcare system, the Company may be the first to offer a complete quality assured vertically integrated CBD Health System for monitoring and recording the effects of CBD on your cardiovascular system.

Disclaimers

This news release contains forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Companys Managements Discussion and Analysis and other disclosure filings with Canadian securities regulators and on the OTC Markets website which is posted on www.sedar.com, http://thecse.com/en/listings/technology/evitrade-health-systems-corp, and http://www.otcmarkets.com/stock/EVAHF/filings.This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE), or any other regulatory authority accepts responsibility for the adequacy or accuracy of this release. The Company does not undertake to update this news release unless required by applicable law.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the U.S. Securities Act), or any state securities law and may not be offered or sold in the United States, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.

Two Hands Corporation Issues Statement About Promotional Activity Involving Its Common Stock Press Release

By

Administrator

-

April 29, 2019

TORONTO, April 26, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — Two Hands Corporation (OTCQB: TWOH), (the “Company”, “Two Hands”), was notified by OTC Markets (“OTC”) on April 22, 2019 of recent trading and promotional activity concerning its common stock. The Company has been informed that the higher-than-average trading volume in the Company’s stock may be the result of promotional activity. The Company has also been informed that an email promoting Two Hands was sent from an unreliable source.

The Company had no knowledge of any subject or content of the promotional campaign until notified by OTC Markets and given a copy of the material. The Company did not have editorial control over the content.

After inquiry, the Company states definitively that its officers, directors and sole controlling shareholder (i.e., shareholders owning 10% or more of the Company’s securities) or any third-party service providers have not, directly or indirectly, been involved in any way with the creation, distribution, or payment of promotional materials related to the Company and its security. Further the Company states definitively that its officers, directors and sole controlling shareholder, have not sold or purchased the Company’s securities within the past 90 days on the open market.

The promotional material primarily consisted of previously disclosed and publicly available information. After a review of the material, the Company determined that while the statements contained therein are neither false nor misleading, they did contain speculative language, and speculation about the future performance of Two Hands shares. The Company encourages those interested in the Company to rely solely on information included in its press releases, combined with its filings and disclosures made with the S.E.C. (www.sec.gov) and OTC Markets Group.

Since July 13, 2018, the Company has engaged Shuttle Digital Solutions Inc. for our social media management in order to create a long-term strategy to engage new users to subscribe to our application.

Since inception, the Company has issued shares of common stock pursuant to private offerings of securities, employee stock option plans, acquisitions and for general corporate purposes, as disclosed or covered in our filings and disclosures made with the S.E.C.

About Two Hands Corporation

Two Hands Corporation is now both an organic hemp based CBD cultivator and application development company that strives to offer the highest quality CBD extract derivatives to be exported under Two Hands CBD Lab brand. For more information, please visit our websites at www.twohandscbdlab.com or www.facebook.com/TwoHandsCBD

Our complete co-parenting solution is offered under the Two Hands App brand. For more information, please visit our websites at www.twohandsapp.com or www.facebook.com/twohandscorp.

Two Hands Gone, for more information, please visit our websites at www.twohandsgone.com or www.facebook.com/twohandsgone/

This press release contains forward-looking statements that involve a number of risks and uncertainties. Any statement not regarding a historical fact is a forward-looking statement. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include, but are not limited to, the company’s ability to finance its planned expansion efforts; the company’s ability to raise funds on acceptable terms; the company’s ability to successfully adapt its business model and such other risks disclosed from time to time in the company’s reports filed with the securities and exchange commission including those on the company’s annual report on form 10-K. The company does not intend to update any of the forward-looking statements after the date of this document to conform these statements to actual results or to changes in management’s expectations, except as required by law.

CONTACT:
Two Hands Corporation
IR@twohandsapp.com
Source: Two Hands Corporation